CEACAM5 and neoplasm: A reasonable follow‐up schedule for LAMN would include abdominopelvic computerized tomography (CT) scans with tumor markers—including carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), and carbohydrate antigen 19‐9 (CA19‐9)—at 1 year, and then annually for several years, with decreasing frequency over time.